Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Skin Neoplasms 2Neoplasms 2Melanoma 2Neoplasm Metastasis 1

Interventions

Ipilimumab 106Nivolumab 101pembrolizumab 90aldesleukin 72Cyclophosphamide 46Interleukin-2 45Temozolomide 36Dacarbazine 32trametinib 31dabrafenib 30fludarabine phosphate 29incomplete Freund's adjuvant 27Bevacizumab 26sargramostim 25Vemurafenib 25fludarabine 22binimetinib 21Radiosurgery 21Paclitaxel 20encorafenib 19Carboplatin 19CTLA-4 Antigen 18cobimetinib 16atezolizumab 15Radiotherapy 14Biopsy 14Sorafenib 13MART-1 Antigen 12talimogene laherparepvec 11montanide ISA 51 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Melanoma × Allovectin-7 × Clear all
NCT00003646 2011-07-07

Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

Vical

Phase 2 Completed
78 enrolled
Dermatologic

Melanoma, Neoplasms, Skin Neoplasms

NCT00044356 2011-07-07

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Vical

Phase 2 Completed
133 enrolled
Dermatologic

Melanoma, Neoplasm Metastasis, Neoplasms, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡